Burlington, Canada

Stephen E Home

This inventor holds 1 USPTO granted patent. Top assignee: Apotex Pharmachem Inc.. Active years: 2010.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen E Home

Introduction

Stephen E Home is a notable inventor based in Burlington, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug formulation. His work has led to advancements that benefit both the industry and patients alike.

Latest Patents

Stephen E Home holds a patent for the "Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions." This patent describes a process for preparing an acid addition salt of ziprasidone base and its intermediates. The method involves exposing the ziprasidone base in solid form to a gaseous acid in a substantially dry environment. This innovative approach enhances the efficiency and effectiveness of the drug formulation process.

Career Highlights

Stephen E Home is currently employed at Apotex Pharmachem Inc., where he continues to work on developing pharmaceutical innovations. His expertise in the field has made him a valuable asset to the company, contributing to its reputation for quality and innovation in drug manufacturing.

Collaborations

Stephen has collaborated with notable colleagues, including Lotfi Derdour and Ks Keshava Murthy. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of pharmaceutical technologies.

Conclusion

In summary, Stephen E Home is a distinguished inventor whose work in pharmaceutical innovations has made a significant impact on drug formulation processes. His contributions continue to shape the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…